Professor Elijah Behr

PProfessor Elijah Behr is a clinical cardiologist and electrophysiologist with an interest in all aspects of the treatment of arrhythmias including ablation and device therapies and cardiac genetic disorders. He completed his medical education at St John's College, Cambridge and Guy's Hospital, London with distinction. He was appointed to his current role in 2007 having undertaken clinical training and research at St George's. He is an international expert in the field of arrhythmias and is Professor in Cardiovascular Medicine at City St George's, University of London where he leads the Cardiovascular and Genomics Research Institute. He runs nationally reputed clinical services diagnosing and treating patients with heart rhythm problems, including individuals and their families with genetic risks for arrhythmia, cardiac arrest and sudden death: the Sudden Arrhythmic Death Syndrome (SADS), channelopathies including long QT and Brugada syndromes; and cardiomyopathies. He leads a research group with interests in these conditions, the genetics and prediction of sudden death risk as well as drug-induced arrhythmia and Sudden Infant Death Syndrome (SIDS). He is past president of the Association for Inherited Cardiac Conditions and the first chairperson of the European Cardiac Arrhythmia Genetics Group of EHRA. He has advised the NHS England Clinical Reference Groups for Cardiovascular and Genomics Services. He leads the NHS England Coronial Sudden Unexpected Death Pilot.

His clinical interests include: • management of families with unexplained sudden deaths, the Sudden Arrhythmic Death Syndrome (SADS) and Sudden Infant Death Syndrome (SIDS) • management of sudden death risk • management and treatment of arrhythmias • ablation of simple and complex arrhythmias including atrial fibrillation • complex device therapy (ICD implantation and biventricular pacing) • ion channel diseases including the long QT and Brugada syndromes • drug-induced arrhythmia and QT prolongation • hypertrophic, dilated and arrhythmogenic right ventricular cardiomyopathies.